Mallinckrodt to spin off generic drugs business; specialty drugs to be based in New Jersey

St. Louis-area pharmaceutical company, Mallinckrodt, announced that it plans to spin off its generic drug business in 2019.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.